We also observed an increase in the frequencies of CD3+T-bet+, CD3+IFN-γ+ cells in the mesenteric lymph nodes (MLN) and spleens from KPN mice after ALK5i treatment (Figure 3(e)), indicating enhanced systemic Th1 immune responses in KPN tumor-bearing mice. This evidence concerns the gene IFNG and neoplasm.